1. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis;Tan-Torres Edeger,2003
2. National Institute for Clinical Excellence and its value judgments;Rawlins;BMJ,2004
3. National Institute for Health and Clinical Excellence. Diabetes (types 1 and 2)— long acting insulin analogues (TA53). 2002. Available from: http://guidance.nice.org.uk/TA53. [Accessed July 28, 2012].
4. The Relative Social Value of Health Gains to Different Beneficiaries: Final Report to NICE;Dolan,2008
5. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY project;Baker;Health Technol Assess,2010